Mongolia vs Myanmar: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy)
Mongolia
75.0%
in 2014
Myanmar
73.0%
in 2014
Mongolia rank
61st
Myanmar rank
62nd
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) over time
- Mongolia
- Myanmar
How they compare
Mongolia currently reports 75.0% against 73.0% in Myanmar, a difference of 2.0%.
The two have swapped places 2 times across 8 shared years of data; in 2005 it was Mongolia ahead.
Mongolia ranks 61st and Myanmar ranks 62nd of 104 countries.
Mongolia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mongolia | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 83.2% | 25.8% | 57.5% | Mongolia |
| 2010s | 78.8% | 78.8% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on cpt (co-trimoxazole preventive therapy), Mongolia or Myanmar?
- Mongolia, at 75.0% against 73.0% in Myanmar as of 2014.
- What is the difference in hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) between Mongolia and Myanmar?
- 2.0%, with Mongolia ahead.
- How many years of comparable data are there for Mongolia and Myanmar?
- 8 years are reported by both, from 2005 to 2014.
- How do Mongolia and Myanmar rank globally for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Mongolia ranks 61st and Myanmar ranks 62nd of 104 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.